Endovascular implants, such as stents, flow diverters, and endografts, have reshaped cardiovascular therapy but still face trade-offs in restenosis, thrombosis, sizing, and fatigue. Conventional, prototype-driven development is expensive and ill-suited to broa... ...

请注册登录后继续浏览